Preferred Label : Cancer Susceptibility Pathway;
NCIt related terms : Role of BRCA1, BRCA2 and ATR in Cancer Susceptibility;
Alternative definition : BIOCARTA: BRCA1 and BRCA2 were identified genetically as breast cancer susceptibility
genes when a single copy of the gene is mutated and are involved in the cellular response
to DNA damage, including blocking cell cycle progression and inducing DNA repair to
preserve the integrity of the genome during cell division. BRCA1 and BRCA2 induce
double-stranded repair of breaks using homologous recombination, in part through activation
of RAD51. BRCA1 acts as a ubiquitin ligase targeting the protein FancD2 that activates
checkpoint control, integrating the ATM response to ionizing radiation and the FA
response to cross-linking agents like mitomycin C. Mutation of one of the several
components of the FA complex involved in maintaining integrity of the genome leads
to the condition Fanconi anemia. One member of the FA complex was recently identified
as BRCA2, which leads to Fanconi anemia when both copies of the gene are mutated.
Another related factor involved in the response of cells to DNA damage is the kinase
ATM. ATM is mutated in patients with AT, a condition with many similar traits to Fanconi
anemia. Like ATM, ATR serves as a checkpoint kinase that halts cell cycle progression
and induces DNA repair when DNA is damaged. Loss of ATR results in a loss of checkpoint
control in response to DNA damage, leading to cell death. Deletion of the ATR gene
in mice is embryonic lethal. ATRIP is a protein that interacts with ATR and is a substrate
for its kinase activity. ATRIP is required for ATR function, and removal of ATRIP
also leads to a loss of checkpoint control of the cell cycle. ATR and ATM kinase targets
include repair enzymes like Rad51, and the checkpoint kinases Chk1 and Chk2, as well
as BRCA1 and BRCA2. The close relationship of the genes involved in breast cancer
and Fanconi anemia has helped illuminate this signaling system, and may help lead
to improved understanding and treatment of these conditions. (This definition may
be outdated - see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_atrbrcaPathway;
Origin ID : C38997;
UMLS CUI : C1516233;
Semantic type(s)
has_gene_product_element
pathway_has_gene_element